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Abstract 25 
Following a myocardial infarction (MI), cardiomyocytes are replaced by scar tissue, which 26 
decreases ventricular contractile function. Tissue engineering is a promising approach to 27 
regenerate such damaged cardiomyocyte tissue. Engineered cardiac patches can be 28 
fabricated by seeding a high density of cardiac cells onto a synthetic or natural porous 29 
polymer. In this study, nanocomposite scaffolds made of gold nanotubes/nanowires 30 
incorporated into biodegradable castor oil-based polyurethane were employed to make 31 
micro-porous scaffolds. H9C2 cardiomyocyte cells were cultured on the scaffolds for one 32 
day, and electrical stimulation was applied to improve cell communication and interaction 33 
in neighboring pores. Cells on scaffolds were examined by fluorescence microscopy and 34 
scanning electron microscopy, revealing that the combination of scaffold design and 35 
electrical stimulation significantly increased cell confluency of H9C2 cells on the 36 
scaffolds. Furthermore, we showed that the gene expression levels of Nkx2.5, atrial 37 
natriuretic peptide (ANF) and natriuretic peptide precursor B (NPPB), which are functional 38 
genes of the myocardium, were up-regulated by the incorporation of gold 39 
nanotubes/nanowires into the polyurethane scaffolds, in particular after electrical 40 
stimulation. 41 
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1. Introduction 46 
Cardiovascular diseases pose the highest risk of death in the world, according to the American 47 
Heart Association Statistics. Every 34 seconds one American dies by heart attack, stroke or other 48 
cardiovascular problems [1]. Currently, treatment options following a myocardial infarction (MI) 49 
and subsequent congestive heart failure are still limited. Pharmacological agents increase the 50 
blood flow but limit ventricular remodeling events and increase cardiac output [2]. Mechanical 51 
devices, such as the left ventricular assist device (LVAD), can only be applied to a limited group 52 
of patients [3]. The only successful treatment option for a severe MI to date is heart 53 
transplantation [4]; however, the lack of suitable donors significantly restricts this option.  54 
As cardiovascular diseases remain a major cause of morbidity and mortality, new strategies in 55 
cardiovascular treatments attract much attention. Among all cardiovascular diseases, MI is one of 56 
the key reasons for heart failure, resulting in heart dysfunction and progressive death of 57 
cardiomyocytes when normal heart function cannot be restored afterwards [5]. Cell therapy has 58 
so far shown only little improvement of cell retention and long-term survival [6].  Instead, 59 
biocompatible 3D scaffold materials might provide a feasible solution, as some structures may 60 
improve cell retention, survival and even cell differentiation [7, 8]. These kinds of scaffolds or 61 
patches can, in principle, be directly implanted on the infarcted tissue with or without cells after 62 
MI [9].  63 
Typically, tissue engineering for cardiovascular regeneration is based on producing biomimetic 64 
and biodegradable materials for scaffold fabrication [4] that ideally integrate signaling molecules 65 
and induce cell migration into the scaffolds [10, 11]. 66 
A material suitable for a tissue engineering-based approach to treat myocardial infarction should 67 
provide an environment that is predisposed to improve electromechanical coupling of the 68 
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cardiomyocytes with the host tissue [10, 12], as well as cardiomyocyte adhesion [9]. This 69 
adhesion is essential for the proliferation of cardiomyocytes and for ventricular function. 70 
Materials suitable for application in cardiac tissue engineering include natural polymers, such as 71 
decellularized myocardium [13], collagen [14], alginate [15], fibrin [16], as well as synthetic 72 
polymers such as polylactic acid (PLA), polyglycolic acid (PGA), their copolymers [17, 18], and 73 
polyurethane (PU) [19, 20]. 74 
Among the above-mentioned materials, PUs are considered a major class of applicable 75 
elastomers because of their good biocompatibility and biodegradability, their high flexibility, and 76 
their excellent mechanical properties [21, 22]. The stiffness of heart muscle varies from 10 kPa 77 
in the beginning of the diastole to 500 kPa at the end of the diastole, therefore an elastic material 78 
having a stiffness in this range would be required for cardiac engineering [23]. Such Young’s 79 
moduli are obtained with biodegradable PUs  [19, 24], which can be synthesized by using 80 
vegetable oils as polyol and aliphatic diisocyanate, resulting in typical degradation times of 81 
several months. Among different grades of PUs, castor oil-based PU shows no toxicity, is low in 82 
cost, and is available as a renewable agricultural resource [25-27]. This grade of biodegradable 83 
PUs has already been widely applied in biomedical engineering, including materials for 84 
peripheral nerve regeneration, cardiovascular implants, cartilage and meniscus regeneration 85 
substrates, cancellous bone substitutes, drug delivery carriers and skin regeneration sheets [28-86 
30]. 87 
Furthermore, tissue engineering applications require that cells are embedded into the material. 88 
Much progress has recently been made in order to fabricate porous polymer scaffolds, in 89 
particular by using salt leaching techniques [31-33]. The success of this method has been shown 90 
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for a variety of soft and hard polymers [34-37], and we have recently established this procedure 91 
for PU [38]. 92 
Although many PU-based materials have been developed for providing vascular grafts, only few 93 
PU scaffolds have so far been studied in the context of myocardial tissue engineering [39, 40], 94 
even though PU is easy to implant into muscle tissue, because it is stiffer than typical hydrogels. 95 
An important goal for myocardial tissue engineering must be the fabrication of materials that 96 
allow for the synchronization of electrical signals, and thus enhance the contraction of 97 
cardiomyocytes in the scaffold material so that a homogeneous total contraction of the 98 
engineered patch is guaranteed. In the study presented here, we fabricated a biodegradable 99 
nanocomposite material by incorporating gold nanotubes/nanowires into PU scaffolds so that the 100 
wired material structure can mimic the electromechanical properties of the myocardium. 101 
To investigate the functionality of these materials as cardiac patches, H9C2 rat cardiomyocyte 102 
cells were seeded on different polyurethane-gold nanotube/nanowire (PU-GNT/NW) composites. 103 
Eventually, electrical stimulation was applied to the cell-scaffold constructs in order to enhance 104 
the functional performance of cardiac scaffolds and to improve cell morphology and alignment. 105 
We used fluorescence and scanning electron microscopy as well as gene expression analysis to 106 
investigate the behavior of cardiomyocyte cells on the scaffolds. We demonstrate that the 107 
adhesion and proliferation of cells significantly depends on the amount of incorporated 108 
GNT/NW, and that an optimum concentration of 50 ppm of GNT/NW can provide the best 109 
environment for cells to achieve native cardiomyocyte function. 110 
 111 
 112 
 113 
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2. Materials and methods 114 
2.1. Synthesis of polyurethane-GNT/NW composite scaffolds 115 
Polyurethane-GNT/NW composites were synthesized according to our previous work [38]. In 116 
brief, gold nanotubes/nanowires (GNT/NW) were made by using template-assisted 117 
electrodeposition and mixed with castor oil /polyethylene glycol-based polyurethane (PU). 118 
Concentrations of 50 and 100 ppm of GNT/NW were used to synthesize two different 119 
composites types. For fabrication of porous scaffolds, 355-600 µm sieved table salt was added to 120 
the PU-GNT/NW solution, then the mixture of PU-GNT/NW and salt was cast in a Teflon mold 121 
of 10 mm diameter and 4 mm thickness. Afterwards, all samples were dried at room temperature 122 
for 48 hours; then the porous scaffolds were placed in distilled deionized water (DDW) for 2 123 
more days to remove the salt. In the following, we refer to the scaffolds as PU-0 for pure PU 124 
scaffolds, PU-50 for scaffolds containing 50 ppm GNT/NW, and PU-100 for those containing 125 
100 ppm GNT/NW.   126 
2.2. Permeability 127 
As it is experimentally difficult to obtain 3D information about pore interconnectivity based on 128 
2D images, Li et al. [41] suggested a simple method of soaking the samples in an ink solution 129 
and then imaging the colored sample. Accordingly, our scaffolds were soaked in a solution of 130 
common blue writing ink for 24 hours and dried at room temperature. Then, a cross section of 131 
samples with a thickness of 1 mm was prepared by cutting with a surgical blade and then 132 
imaging the samples with a Nikon (TS100) inverted microscope (10X objective). This treatment 133 
provides information on the interconnectivity of pores as well as on their accessibility from 134 
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neighboring pores. Porosity was calculated by ImageJ [42] using a manually set intensity 135 
threshold. 136 
2.3. Cell culture and electrical stimulation 137 
H9C2 rat cardiomyocytes were purchased from the European Collection of Cell Cultures 138 
(ECACC, Germany) and maintained in Dulbecco's Modified Eagle's medium (DMEM, 139 
Biochrom, Germany), supplemented with 10% fetal bovine serum (FBS, Biochrom, Germany) 140 
and 1% penicillin and streptomycin (100 U/ml, Biochrom, Germany) at 37 ºC and 90% humidity. 141 
H9C2 is a subclone of the original clonal cell line derived from embryonic rat heart tissue. Cells 142 
were sub-cultured regularly and used up to passage 6. Prior to the experiments, PU scaffolds 143 
were sterilized using ethylene oxide gas and placed in 10 ml of sterilized phosphate buffered 144 
saline (PBS) for 2 hours. Cells (106) were seeded per cylindrical scaffold (diameter: 10 mm, 145 
thickness: 4 mm) and incubated overnight to allow cell attachment. On the following day, cells 146 
were stimulated using a function generator (Toellner, Germany) with a square pulse of 1 V/mm 147 
amplitude, pulse duration of 2 ms, at a frequency of 1 Hz for 15 minutes. This procedure was 148 
repeated on three consecutive days, once per day [43, 44]. Stainless steel 304 was used as the 149 
electrode material for electrical stimulation. Compared to titanium electrodes and titanium 150 
electrodes coated with titanium nitrate, the electrical field was stable in stainless steel 304 151 
electrodes over the whole time of stimulation [43]. The cell-scaffold constructs were left in the 152 
incubator for one more day. 153 
8 
 
2.4. Staining with Calcein and Hoechst 154 
Calcein was used for staining viable cells and Hoechst for staining cell nuclei. Five repeats of 155 
each scaffold group were stained with both Calcein AM and Hoechst after 1 day of cell culture 156 
before stimulation and another 5 repeats of each group were stained on the fourth day after cell 157 
seeding and electrical stimulation. For Calcein staining, the samples were rinsed once with 158 
DMEM and incubated with a 1 µg/ml solution of Calcein (BD Bioscience, Germany) in DMEM 159 
for 10 minutes at 37ºC. Afterwards, the samples were washed with DMEM twice, stained with 160 
10 µg/ml Hoechst 32258 (Invitrogen, Germany) in PBS and incubated for 20 minutes at 37 ºC. 161 
Then, the samples were washed extensively with PBS and imaged using an Olympus BX43 162 
fluorescence microscope (Olympus, Japan) with a 10X objective. Cell confluency was measured 163 
as the ratio of the area stained with Calcein to the whole surface of a scaffold in 2D images using 164 
ImageJ [42]. This test was performed in two independent experiments and at least 5 images were 165 
taken in each experiment. 166 
2.5. Gene expression 167 
Cells were lysed in TriSure (Bioline, Luckenwalde, Germany) and RNA extraction was 168 
performed according to the manufacturer's protocol. In order to obtain enough RNA, cells grown 169 
on 3 scaffolds were pooled. After RNA extraction, aliquots of 200 ng total RNA from each group 170 
were reverse transcribed into cDNA, using a cDNA synthesis kit (AmpTec, Hamburg, Germany) 171 
and the provided oligo dT-V primer. Subsequently the cDNAs were purified utilizing the spin 172 
columns and buffers provided with the cDNA synthesis kit. Gene expression was analyzed by 173 
qRT-PCR using a Rotorgene 3000 (Corbett, LTF, Wasserburg, Germany). For each qRT-PCR 174 
analysis, 2.5 µl of the above-mentioned cDNA (=10 ng total RNA) was used; total reaction 175 
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volume was 25 µl each and cycling conditions were as follows: 10 min initial denaturation at 176 
95°C followed by 45 cycles of 20 s denaturation at 95°C, 20 s annealing, for details see table 1, 177 
and 20 s elongation at 72°C. At the end of the cycling program a melt curve analysis was 178 
performed starting at the actual annealing temperature.  All samples were run in duplicates. 179 
Gene-specific primers were obtained from TibMolBiol (Berlin, Germany). Primers for atrial 180 
naturiuretic factor (ANF), Connexin 43 (Con43), Cardiac troponin I (cTnl; Tro I), cardiac 181 
Troponin T type 2 (Tnnt2; Tro II), NK2 homeobox 5 (Nkx2.5), Myocyte enhancer factor 2C 182 
(Mef2c) and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) were designed using the 183 
web-based “Primer 3” program. Primers for ß-cardiac myosin heavy chain (β-MHC), natriuretic 184 
peptide B (NPPB) and GATA binding protein 4 (GATA 4) were published previously [45, 46]; 185 
as were the primers for Beta-2-microtubulin (B2M), TATA box binding protein (TBP) [47] and 186 
those for 18S ribosomal protein mRNA (18sr RNA) [48]. The SYBR Green based qPCR mix 187 
was purchased from Peqlab (Erlangen, Germany). Threshold levels for Ct-determination were 188 
chosen manually. Primer sequences and annealing temperatures are provided in table 1. 189 
2.6.  Scanning Electron Microscopy 190 
The morphology of the porous Polyurethane-GNT/NW nanocomposites was studied by field 191 
emission scanning electron microscopy (FESEM; Philips S-4160). 192 
For observation of cell-scaffold constructs, the samples were fixed in 3% glutaraldehyde (Sigma-193 
Aldrich, Germany) solution in PBS, and then dehydrated with a graded ethanol (Walter CMP, 194 
Germany) series (30%, 50%, 70%, 80%, 90%, 96%), 20 minutes each. Dehydration was finished 195 
with 100% ethanol overnight. The samples were sectioned with the thickness of 7 µm from the 196 
top side, further dehydrated using a critical point dryer (CPD 030, Balzers, Switzerland), and 197 
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coated with gold (Ion Tech Ltd., Teddington, U.K.) before SEM imaging (XL 20, Philips, The 198 
Netherlands).  199 
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Table 1. Primer sequences and annealing temperatures for qRT-PCR analysis of the 200 
housekeeping and target genes. 201 
Gene symbol and 
accession number  
Gene name Primer sequence [5’--3’] Annealing 
temperature 
[°C] 
ANF 
NM_012612.2 
Atrial Naturiuretic factor forward: atcaccaagggcttcttcct 
reverse:  ccaggtggtctagcaggttc 
64 
GAPDH 
NM 017008 
Glyceraldehyde-3-phos-
phate dehydrogenase 
forward: ggcattgctctcaatgacaa 
reverse: tgtgagggagatgctcagtg 
60 
β-MHC 
X15939.1 
ß-cardiac myosin heavy 
chain 
forward: gagtggacgtttattgacttcgg 
reverse: gcctttctttgctttgccttt 
64 
NPPB 
NM_031545                 
Natriuretic peptide B forward: cagctctcaaaggaccaagg 
reverse: cggtctatcttctgcccaaa 
64 
GATA4 
NM_144730.1 
GATA binding protein 4 forward: gtgccaactgccagactacc 
reverse: agccttgtggggagagcttc 
62 
B2M 
NM_012512.2 
Beta-2-microtubulin forward: ccgtgatctttctggtgctt 
reverse: atttgaggtgggtggaactg 
60 
TBP 
NM_001004198.1 
TATA box binding protein forward: ttctgggaaaatggtgtgc 
reverse: cccaccatgttctggatctt 
60 
18sr RNA 
NM_078617.3 
18S ribosomal protein 
mRNA 
forward: accgcggttctattttgttg 
reverse: ctgatcgtcttcgaacctcc 
60 
Con43 
AH003191.2 
Connexin 43 forward: tgaaagagaggtgcccagaca 
reverse: cgtgagagatggggaaggact 
60 
cTnl (Tro I) 
M57679.1 
Cardiac troponin I  forward: gccctcaaactttttctttcgg 
reverse: ctgatgctgcagattgcgaag 
60 
Tnnt2 (Tro II) 
NM_012676.1 
Troponin T type 2 (cardiac) forward: caaggaacagagctttgtcgaa 
reverse: cacaacctagaggccgagaagt 
60 
Nkx2.5 
NM_053651.1 
NK2 homeobox 5  forward: cgcccttctcagtcaaagac 
reverse: gaaagcaggagagcacttgg 
62 
Mef2c 
XM_006231731.2 
Myocyte enhancer factor 2C  forward: ttgccttccctgttcatacc 
reverse: ggcaaaccatctgaagcaat 
60 
2.7. Statistical analysis 202 
Cell confluency is presented as mean value ± standard deviation. Differences between groups 203 
were analyzed by analysis of variance (ANOVA) followed by Tukey’s multiple comparison test. 204 
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For gene expression analysis, the results are presented as mean value ± standard deviation. qRT-205 
PCR data were analyzed according to the ∆∆Ct method [30] using the mean Ct value of the 206 
housekeeping genes. Fold changes of expression levels were calculated as described previously 207 
[30] and the obtained values were used for statistical analysis. 208 
3. Results 209 
3.1.  Permeability of the scaffolds 210 
An essential prerequisite for a cardiac patch material is to ensure porosity above the percolation 211 
threshold, so that the cells can grow deeply into the scaffold without undergoing hypoxia-212 
induced cell death. In figure 1, we present images of scaffold cross-sections after incubation in 213 
ink. Our results show that all imaged scaffolds were homogeneously colored by the ink, 214 
regardless of their GNT/NW content. This confirmed that the pores were almost uniformly 215 
distributed and interconnected. Colored pores were found to be accessible either directly or via 216 
adjacent pores. The porosities of the scaffolds were above 90% in all samples. By increasing the 217 
amount of gold content in the polymer solution during polymerization, the interconnectivity of 218 
the pores was improved, presumably due to the presence of chloroform in the gold-containing 219 
samples, which leads to the activation of a solvent casting mechanism in addition to salt 220 
leaching. Furthermore, we observed that PU-100, having the highest gold content and smallest 221 
polymer concentration, was the most uniform in pore size and distribution and had the largest 222 
pores (Fig. 1 c). SEM images of scaffolds also confirmed the largest pores in PU-100 (Fig. 1 d) 223 
compared to PU-0 or PU-50 (Fig. 1 e-f) 224 
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3.2.  Cell adhesion and growth on scaffolds 225 
Cells of the myocardium need to adhere and proliferate on the material patch in order to form a 226 
functional cell network before the scaffold material is degraded. To compare how cell adhesion 227 
and growth are influenced by the different scaffold types and by additional electrical stimulation, 228 
we investigated the morphology of H9C2 cells stained with Calcein (cell body) and Hoechst 229 
(nucleus) on different scaffolds with and without electrical stimulation in figure 2. Figures 2a-c 230 
clearly show that cells after 1 day of incubation spread best on PU-50 compared to PU-0 or PU-231 
100, and they are more homogeneously distributed within the scaffolds than cells on the other 232 
two scaffold types (PU-0 and PU-100). In particular, on the PU-100 scaffold H9C2 cells 233 
preferred to attach to each other and formed large clumps rather than spreading on the sample. 234 
On samples that had undergone electrical stimulation, the results were distinctly different: 235 
whereas cell spreading was not significantly influenced by electrical stimulation on PU-0 236 
scaffolds, it was significantly enhanced on the gold-containing PU-50 and PU-100 scaffolds. 237 
This observation is even more pronounced in the quantitative analysis of confluency (Figure 3).  238 
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 239 
Fig. 1. (a)-(c) Light microscopy image demonstrating the permeability of ink into the pores. (a) 240 
PU-0, (b) PU-50, and (c) PU-100. The pores are interconnected and almost uniform in size 241 
throughout the cross-section of the scaffold materials. SEM images show the structure of pores 242 
in different samples of (d) PU-0, (e) PU-50, and (f) PU-100. PU-100 showed the most 243 
interconnected and the largest pores compared to PU-0 or PU-50. 244 
Furthermore, we checked if cell alignment after electrical stimulation was enhanced which 245 
would mimic the natural response of cells to electromechanical coupling in the heart. The 246 
representative images in Fig. 2 clearly show that the cells were aligned only in gold-containing 247 
scaffolds, whereas no alignment was observed in PU-0. Furthermore, no significant differences 248 
in cell alignment were observed when cells were seeded on PU-50 and PU-100 scaffolds. 249 
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 250 
Fig. 2. Staining of H9C2 cells nuclei (Hoechst, blue) and cytoplasm (Calcein, green) before (a, b, 251 
c; cells cultured 1 day) and after (d, e, f; cells cultured 4 days) electrical stimulation on PU-0 (a, 252 
d), PU-50 (b, e) and PU-100 (c, f). Scale bar is 50 µm. Arrows indicate the direction of cell 253 
alignment.  254 
Figure 3 summarizes our results for H9C2 cell confluency on scaffolds before and after 255 
stimulation. Confluency increased by 39% and 14% after stimulation for PU-50 and PU-100 256 
scaffolds, respectively. However, at the same time cell confluency was not significantly 257 
influenced by electrical stimulation in the samples without gold (PU-0). When the samples were 258 
incorporated with gold, a significant increase was found between PU-0 and PU-50 after 259 
stimulation. An even more marked increase was found for PU-50 before and after stimulation, 260 
however for PU-100, no significant difference was found.  261 
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 262 
Fig. 3. Cell confluency on scaffolds before (a, c, e) and after (b, d, f) electrical stimulation. 263 
ANOVA analysis was used for evaluating data significance (*p < 0.05, **p < 0.01). 264 
3.3.  Gene expression 265 
In order to investigate if the incorporation of gold into porous PU scaffolds in combination with 266 
electrical stimulation can facilitate the function of H9C2 cardiomyocyte on the scaffolds 267 
similarly to native myocardium, we investigated the expression of several relevant genes using 268 
qRT-PCR analysis. To this end, we evaluated gene expression levels of different cardiac 269 
transcription factors (GATA4, NPPB, ANF, and β-MHC) as well as gene expression levels of 270 
Con43, cTnl (Tro I), Tnnt2 (Tro II), Nkx2.5 and Mef2c in the H9C2 cardiomyocytes on different 271 
scaffolds and as a function of electrical stimulation. The expression levels of the housekeeping 272 
genes GAPDH, B2M, TBP and 18sr RNA were also examined. Expression levels of GAPDH, 273 
B2M, TBP and 18sr RNA were not significantly affected by any of the treatments (fold changes 274 
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<2; data not shown) and were therefore used to normalize gene expression levels of the genes of 275 
interest, namely GATA4, NPPB, ANF, β-MHC, Con43, cTnl (Tro I), Tnnt2 (Tro II), Nkx2.5 and 276 
Mef2c.  277 
Figure 4 shows ANF, NPPB, Tnnt2 (Tro II), Nkx2.5 and Mef2c gene expression in H9C2 278 
cardiomyocytes. In Fig. 4a and c, ∆ct values obtained in cells grown on normal culture dishes (as 279 
control group) were set as “1” and fold changes obtained in cells grown on PU-0, PU-50, PU-100 280 
were calculated as described elsewhere [30]. Similarly in Fig. 4b and d, values obtained from 281 
cells grown on pure PU-0 scaffolds alone were set as “1” and fold changes obtained in cells 282 
grown on PU-50 or PU-100 were calculated as described elsewhere [30]. Dotted lines indicate 2-283 
fold changes of gene expression as described previously and ± 2-fold changes in gene expression 284 
levels are considered statistically significant [30]. 285 
Compared to tissue culture plastic surfaces, all our PU samples showed, regardless of their 286 
GNT/NW content, upregulated gene expression of some cardiac transcription factors in H9C2 287 
cells. ANF, NPPB, Tnnt2 (Tro II), Nkx2.5 and Mef2c expression levels were already increased 288 
when H9C2 cells were grown on pure PU-0 scaffolds (3.26±0.22 fold (ANF), 111.3±4.82 fold 289 
(NPPB),   3.27±0.22 (Mef2c), 27.76±2.29 (Nkx2.5) and 6.49±1.29 [Tnnt2 (Tro II)]) compared to 290 
cells grown in normal culture dishes. Growing the cells on PU-50 resulted in a distinct increase 291 
of ANF, NPPB and Nkx2.5 expression levels, which were 15.6±0.73, 560.76±3.58 and 292 
79.34±1.76 times higher, respectively, than those detected in cells grown in normal culture 293 
dishes. Gene expression levels of Mef2c and Tnnt2 were only marginally increased when cells 294 
were grown on PU-50 (3.31±0.22 for Mef2c and 7.82±0.16 for Tnnt2). Expression changes of 295 
the cells growing on PU-100 were as follows: 8.2±0.49 fold increase of ANF- and 240.1±5.44 296 
fold increase of NPPB-expression, when compared to the levels detected in cells grown in 297 
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normal culture dishes (Fig. 4a); Mef2c gene expression was only 1.62±0.11 times higher when 298 
cells were grown on PU-100, similarly Nkx2.5 was only 31.94±1.19 times higher when 299 
compared to cells grown in normal culture dishes and Tnnt2 gene expression levels were 300 
10.41±1.16 higher (Fig. 4c). Interestingly, the fold changes in ANF- and NPPB-expression, when 301 
compared to levels detected in cells grown on PU-0 were rather similar: 4.78±0.23 and 302 
4.94±0.31 in ANF- and NPPB-expression, respectively, in cells grown on PU-50 and 2.52±0.11 303 
and 2.12±0.09ANF- and NPPB-expression, respectively, in cells grown on PU-100 (Fig. 4b). 304 
This, however, was not the case for Mef2c, Nkx2.5 and Tnnt2 leading for Mef2c gene expression 305 
a 2.01±0.26 fold decrease when grown on PU-100 and a 2.86±0.26 fold increase when grown on 306 
PU-50, while all other conditions were not significantly influenced, and Tnnt2 expression was 307 
not at all affected when compared to PU-0 scaffolds (Fig. 4d). GATA 4, Con43 and cTnl (Tro I) 308 
expression was not affected by any of the different scaffolds, and β-MHC expression could not 309 
be detected in these cells, but was detectable in cDNA synthesized from total RNA of normal rat 310 
embryonic tissue (Rat RNA: 17-19 days; amsbio biotechnology, Abingdon, United Kingdom), 311 
which was used as a positive amplification control (data not shown). 312 
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 313 
Fig. 4. Fold change in (a, b) ANF, NPPB; and (c, d) Mef2C, Nkx2.5 and Tnnt2 gene expression 314 
in H9C2 cardiomyocytes. ∆ct values obtained in cells grown on (a, c) normal culture dishes 315 
(control) and (b, d) on pure PU, were set as “1”. Dotted lines indicate a 2-fold change of gene 316 
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expression and gene expression changes above such a 2-fold change were considered statistically 317 
significant. 318 
3.4.  Scanning Electron Microscopy 319 
SEM images of H9C2 cells on different samples after 3 days of electrical stimulation are shown 320 
in figure 5. The images clearly support our findings from the cell staining experiments, as more 321 
cells are adhering to the PU-50 scaffold than to the other scaffolds. Furthermore, cells adhering 322 
to PU-100 had a morphology similar to cardiomyocytes in native tissue. The results are in 323 
agreement with our results on cell confluency, as there are more cells adhering to PU-50 than to 324 
the other scaffolds. In general, imaging cells inside porous scaffolds was very challenging due to 325 
the spatial conformation of pores, in which the cells can hide behind the pore walls (Fig. 5d). 326 
These results prove that our nanocomposite scaffolds indeed support cell attachment much better 327 
compared to gold-free PU-0 scaffolds. This is probably due to a larger number of interconnected 328 
pores in the gold-containing samples, providing higher probabilities for cells to grow through the 329 
scaffold pores, thus improving cell adhesion and proliferation.     330 
4. Discussion  331 
In the work presented here, we investigated a novel method using the combined effect of a 332 
polyurethane-gold nanotube/nanowire composite material and electrical stimulation of 333 
cardiomyocyte cells. This specific composite material of nano-sized gold incorporated into a 334 
porous biodegradable polyurethane matrix was chosen in order to improve the transmission and 335 
synchronization of electrical signals in the material and thus increase the natural functionality of 336 
cardiomyocytes. The feasibility of this approach of incorporating gold nanoparticles into scaffold 337 
21 
 
materials for applications such as cardiac patches has recently been shown for an alginate matrix 338 
[49]. Such alginate matrices have a very low elastic modulus of only a few kPa and are 339 
viscoelastic [50]. 340 
 341 
Fig. 5. SEM images of cells on (a) PU-0, (b) PU-50, and (c) PU-100 on day 4 after electrical 342 
stimulation. (d) A single cell cultured on PU-100 hiding behind the pore walls, a single 343 
cardiomyocyte cell cultured on glass slide is shown in the inset. Cells spread better on those 344 
samples containing gold and the best cell spreading is obtained on PU-100. Arrows point at 345 
single cells.  346 
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An ideal material for cardiac tissue engineering would, however, be purely elastic in order to 347 
mimic the complicated mechanical properties of native heart tissue without tearing during 348 
systolic pressure or prohibiting contractile force. The compressive modulus of native heart tissue 349 
has been reported to be 425 kPa at the systole [49]. We have recently shown that PU-GNT/NW 350 
composites can provide the mechanical properties required for this purpose, i.e. elasticity can be 351 
tuned between 200 kPa and 240 kPa [38]. Incorporation of gold nanoparticles in PU substrates 352 
changed the physicochemical properties of PU and improved fibroblast cell attachment [51], and 353 
gold in the form of nanowires allowed the formation of conductive bridges between pores and 354 
enhanced cell communication [38, 49]. Addition of GNT/NW caused the formation of hydrogen 355 
bonding with the polyurethane matrix and improved the thermomechanical properties of 356 
nanocomposites. Higher crosslink density and better cell attachment and proliferation were 357 
reported in polyurethane containing 50 ppm GNT/NW [38]. Additionally, PU and PU 358 
composites showed controllable degradation properties using different polyols during the 359 
synthesis process [21, 22]. The polymeric matrix in PU-GNT/NW composites can therefore be 360 
replaced by extracellular matrix (ECM) due to the controlled degradation of PU [52, 53]. After 361 
degradation of the scaffold matrix, the gold nanoparticles would remain in the cardiac muscle 362 
ECM, which should not harm the cardiac tissue as the gold concentration is comparably low, 363 
thus cytotoxicity should be negligible [54]. Additionally, the concentration of gold in most 3D 364 
structures varies from 0.0001 % wt. to 15 % wt.  and the low concentration of ppm has been 365 
shown to affect the cellular activity [55]. 366 
Since intact myocardium tissue contains a high density of cardiomyocytes and is known for 367 
heavy oxygen consumption, pore interconnectivity and pore uniformity are essential properties 368 
of any tissue engineered cardiac patch material, as they guarantee nutrition and oxygen 369 
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exchange. Both are, for example, necessary to  facilitate cell migration [56]. Additionally, the 370 
size and orientation of pores has been reported to affect cell alignment [57]. We used 355-600 371 
µm sieved table salt in scaffold fabrication by a porogen-leaching method so that a microscopic, 372 
interconnected, and homogeneous pore structure was formed (Fig. 1). Nutrients should therefore 373 
easily be transported deeply into the scaffolds.  374 
In addition to the relevance of material selection for cardiac tissue engineering, signaling factors 375 
also play a major role for engineering a functional tissue patch. Proper signaling might be 376 
induced by mechanical stimulation or electrical stimulation, similar to the conditions found in 377 
intact myocardium. A recent study has shown that in heart mimicking constructs, applying only 378 
mechanical stimulation was not a proper signaling factor to keep cardiomyocytes functional [58]. 379 
Instead, it has been suggested that an excitation-contraction coupling in cell-scaffold constructs 380 
is required for the proper function of cardiomyocyte tissue. This can be achieved by electrical 381 
stimulation just as in native heart, where the mechanical stretch of the myocardium is induced by 382 
electrical signals [58]. Other studies have already shown that even small physiological fields (75-383 
100 mV/mm) can stimulate the orientation, elongation and also migration of endothelial cells 384 
[12]. 385 
In this study, we investigated the orientation and adhesion of cardiomyocyte cells on different 386 
PU scaffolds after 3 days of consecutive electrical stimulation (Fig. 2). Only on gold-containing 387 
scaffolds cells had changed their alignment after four days. Before stimulation, no significant 388 
difference of cell morphology was found, whether gold had been incorporated in the scaffolds or 389 
not. Furthermore, cell proliferation was not enhanced as a result of gold incorporation. On PU-0, 390 
no cell alignment was observed even after electrical stimulation; on both PU-50 and PU-100, 391 
cells were aligned on day 4 after electrical stimulation. It is interesting that after stimulation, PU-392 
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50, not PU-100, showed the greatest amount of cells, although cells showed on PU-100 a 393 
morphology that was most similar to their natural morphology. 394 
In our experiments, the alignment of cells was rearranged towards the direction of the applied 395 
electrical field. A similar cell alignment improvement was reported by Au et al. [59] for 396 
fibroblasts and cardiomyocytes. Furthermore, the cells were re-oriented due to electrical 397 
stimulation only on PU-GNT/NW composites (Fig. 2). Particularly for endothelial cells, it is 398 
well-known that electrical stimulation can change cell elongation, alignment, and migration [10]. 399 
Here, we made use of this effect in order to electrically polarize the cardiomyocytes seeded on 400 
PU-GNT/NW scaffolds to provide a better microenvironment for their adhesion, elongation and 401 
function.  402 
It has previously been reported that a square, biphasic electrical pulse of 2 ms duration provided 403 
cell coupling similar to that present in in vivo environments after 8 days of stimulation [58] and a 404 
small electrical field of 200 mV/mm caused a fully-oriented cell network [12]. Despite all of 405 
these electrical stimulations, Tandon et al. [44] showed that the alignment of cardiomyocyte cells 406 
was only affected by surface topography and not by applying an electrical field; however, our 407 
result demonstrated that electrical stimulation indeed facilitates the behavior of only those cell-408 
scaffold constructs that contained gold.  409 
The morphology and distribution of cells investigated by SEM confirmed the essential role of 410 
pore size and distribution in the scaffolds (Fig. 5). We observed a marked difference in terms of 411 
both cell number and cell morphology between pure PU and PU-GNT/NW composites. In PU-412 
GNT/NW composites, where chloroform had been used during fabrication, the pores were bigger 413 
and more interconnected (Fig. 1). Therefore, more cells could migrate into the scaffold and could 414 
easily be observed. However, we found that cells on PU-100 were closer to their native 415 
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morphology. This is consistent with our previous result that 50 ppm gold provides optimum 416 
adhesion conditions for mesenchymal cell attachment [38], presumably by changes in surface 417 
energy in response to the incorporation of gold. Other studies have shown that an optimum 418 
amount of gold (43-50 ppm) caused a microphase separation in the chemical composition of PU, 419 
hence improving hydrophilicity [55]. Gold nanoparticles in a concentration of 43.5 ppm in 420 
polyurethane matrix have been shown to cause minimum inflammatory response in vitro and in 421 
vivo, and improve biocompatibility [51]. Our study shown here suggests that the PU-50 scaffolds 422 
provide optimum conditions for a cardiac tissue engineering material.  423 
Our gene expression analysis of specific markers in myocardium tissue clearly showed changes 424 
in the expression levels of functional cardiac genes, clarifying the role of gold nanoparticle 425 
incorporation into PU and the importance of electrical stimulation. Five different specific genes 426 
were investigated (Fig. 4). The expression of both ANF and NPPB was significantly up-427 
regulated (Fig. 4a); the highest up-regulation level was determined on PU-50. The ANF gene is 428 
highly expressed by cardiomyocytes when arteriosclerosis has occurred and a decrease has been 429 
reported during maturation of ventricular cells [40]. ANF is particularly a marker of 430 
cardiomyocyte differentiation [60, 61]. Therefore, the marked increase of this gene’s expression 431 
in PU-50 and PU-100 found here is assumed to be a positive response to atrial stretch due to the 432 
electrical stimulation. Therefore, we conclude that PU-GNT/NW scaffolds can accelerate 433 
cardiomyocyte response to the stresses induced by electrical stimulation, decreasing the progress 434 
of cardiac hypertrophy. NPPB marks any overstretching in myocardial tissue and acts similar to 435 
ANF, but with lower affinity. As it has been shown that in native heart, mechanical stretch is 436 
initiated by electrical signals [58], increases in the expression levels of these genes reflect the 437 
overstretching of the cell-scaffold constructs, particularly in the PU-50 samples (Fig. 4a). 438 
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Similarly, incorporation of gold induced in our studies a significant increase in gene expression 439 
level of the early cardiac transcription factors Nkx2.5 and Mef2c (Fig. 4c). Mef2c play a role in 440 
myogenesis, maintaining the differentiated state of muscle cells. Nkx2.5 also functions in heart 441 
formation and development [5, 15]. This implies that 50 ppm of GNT/NW is an optimum 442 
concentration for stimulating the expression levels of important cardiac differentiation markers 443 
and of myogenesis. 444 
5. Conclusions  445 
In this study we investigated different properties of cardiomyocytes on porous nanocomposite 446 
scaffolds formed by a biodegradable polyurethane matrix with incorporated gold nanoparticles 447 
(PU-GNT/NW). Cardiomyocyte adhesion and proliferation were strongly increased in response 448 
to electrical stimulation on PU-GNT/NW composites within 4 days. After 4 days of incubation 449 
and electrical stimulation on the scaffolds, cardiomyocytes on PU-GNT/NW samples showed a 450 
more native morphology and enhanced proliferation compared to gold-free PU-0. Only small 451 
differences in cell behavior were observed between PU-50 and PU-100, where particularly PU-452 
50 induced optimum cell distribution and spreading, as well as the largest up-regulated 453 
expression levels of genes relevant to cardiac differentiation and hypertrophy. Taken together, 454 
our data suggest that nanocomposites made from porous and biodegradable polyurethane 455 
scaffolds with an optimized content (50 ppm) of gold nanowires/nanotubes in combination with 456 
electrical stimulation are promising materials for future applications in cardiac tissue 457 
engineering. 458 
 459 
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